Please be advised that the format of evaluation reports shared on the NICE website has recently changed, for ease of user navigation between individual documents contained in the report.

It is a requirement of the new (PDF portfolio) format that Adobe Reader is used to view the document. Please follow the link at the bottom of this page to download Adobe Reader if required.

If you have any feedback on the new format please contact the Project Manager for this appraisal.

Macular degeneration (wet age-related) - aflibercept (1st line): evaluation report

01 - Pre-Meeting Briefing prepared by NICE

02 - Submission from the technology manufacturer - Bayer

03 - PAS Submission from the technology manufacturer - Bayer

04 - NICE request to the manufacturer for clarification on their submission

05 - Manufacturer clarification response

06 - Consultee submission - Macular society and RNIB (joint submission)

07 - Consultee submission - Royal College of Opthalmologists

08 - Patient expert personal perspective - Yelf

09 - Patient expert personal perspective - Eaglan

10 - Clinical expert personal perspective - Johnston

11 - Clinical expert personal perspective - Pearce

12 - Clinical expert personal perspective - Sivaprasad

13 - Evidence Review Group report prepared by Aberdeen HTA Group

14 - Evidence Review Group report - factual accuracy check